Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

Zymeworks (ZYME) Equity Average (2022 - 2025)

Zymeworks' Equity Average history spans 2 years, with the latest figure at $436.6 million for Q3 2023.

  • For Q3 2023, Equity Average rose 117.21% year-over-year to $436.6 million; the TTM value through Sep 2023 reached $436.6 million, up 117.21%, while the annual FY2022 figure was $371.0 million, 12.6% up from the prior year.
  • Equity Average for Q3 2023 was $436.6 million at Zymeworks, down from $461.2 million in the prior quarter.
  • Across five years, Equity Average topped out at $483.2 million in Q1 2023 and bottomed at $201.0 million in Q3 2022.